L-Glutamine

Details

Top
Internal ID 60985575-3bf8-40af-bad1-35561691e5f5
Taxonomy Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Alpha amino acids and derivatives > Alpha amino acids > L-alpha-amino acids
IUPAC Name (2S)-2,5-diamino-5-oxopentanoic acid
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1
InChI Key ZDXPYRJPNDTMRX-VKHMYHEASA-N
Popularity 99,259 references in papers

Physical and Chemical Properties

Top
Molecular Formula C5H10N2O3
Molecular Weight 146.14 g/mol
Exact Mass 146.06914219 g/mol
Topological Polar Surface Area (TPSA) 106.00 Ų
XlogP -3.10
Atomic LogP (AlogP) -1.34
H-Bond Acceptor 3
H-Bond Donor 3
Rotatable Bonds 4

Synonyms

Top
glutamine
56-85-9
Levoglutamide
L-(+)-Glutamine
Glutamic acid amide
Cebrogen
Stimulina
glumin
Levoglutamid
Glavamin
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of L-Glutamine

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6799 67.99%
Caco-2 - 0.9372 93.72%
Blood Brain Barrier + 0.8500 85.00%
Human oral bioavailability + 0.7857 78.57%
Subcellular localzation Mitochondria 0.7313 73.13%
OATP2B1 inhibitior - 0.8484 84.84%
OATP1B1 inhibitior + 0.9754 97.54%
OATP1B3 inhibitior + 0.9571 95.71%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.9603 96.03%
P-glycoprotein inhibitior - 0.9917 99.17%
P-glycoprotein substrate - 0.9820 98.20%
CYP3A4 substrate - 0.7795 77.95%
CYP2C9 substrate - 0.8062 80.62%
CYP2D6 substrate - 0.7879 78.79%
CYP3A4 inhibition - 0.8936 89.36%
CYP2C9 inhibition - 0.9741 97.41%
CYP2C19 inhibition - 0.9761 97.61%
CYP2D6 inhibition - 0.9600 96.00%
CYP1A2 inhibition - 0.9583 95.83%
CYP2C8 inhibition - 0.9952 99.52%
CYP inhibitory promiscuity - 0.9932 99.32%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8300 83.00%
Carcinogenicity (trinary) Non-required 0.6980 69.80%
Eye corrosion - 0.9886 98.86%
Eye irritation - 0.8291 82.91%
Skin irritation - 0.8866 88.66%
Skin corrosion - 0.6841 68.41%
Ames mutagenesis - 0.7600 76.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8598 85.98%
Micronuclear - 0.5200 52.00%
Hepatotoxicity + 0.7750 77.50%
skin sensitisation - 0.9622 96.22%
Respiratory toxicity + 0.7556 75.56%
Reproductive toxicity - 0.6333 63.33%
Mitochondrial toxicity + 0.8125 81.25%
Nephrotoxicity - 0.8449 84.49%
Acute Oral Toxicity (c) IV 0.6418 64.18%
Estrogen receptor binding - 0.9667 96.67%
Androgen receptor binding - 0.8794 87.94%
Thyroid receptor binding - 0.9095 90.95%
Glucocorticoid receptor binding - 0.8360 83.60%
Aromatase binding - 0.9095 90.95%
PPAR gamma - 0.7963 79.63%
Honey bee toxicity - 0.9649 96.49%
Biodegradation + 0.9750 97.50%
Crustacea aquatic toxicity - 0.9200 92.00%
Fish aquatic toxicity - 0.9408 94.08%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL1293237 P54132 Bloom syndrome protein 2.8 nM
Potency
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4040 P28482 MAP kinase ERK2 98.46% 83.82%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.57% 96.09%
CHEMBL233 P35372 Mu opioid receptor 91.29% 97.93%
CHEMBL221 P23219 Cyclooxygenase-1 88.42% 90.17%
CHEMBL3060 Q9Y345 Glycine transporter 2 87.34% 99.17%
CHEMBL3976 Q9UHL4 Dipeptidyl peptidase II 86.36% 92.29%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 83.54% 96.95%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 82.71% 95.17%
CHEMBL236 P41143 Delta opioid receptor 81.40% 99.35%
CHEMBL1795117 Q8TEK3 Histone-lysine N-methyltransferase, H3 lysine-79 specific 81.16% 93.56%
CHEMBL1907591 P30926 Neuronal acetylcholine receptor; alpha4/beta4 80.88% 100.00%

Cross-Links

Top
PubChem 5961
NPASS NPC197087
ChEMBL CHEMBL930
LOTUS LTS0263175
wikiData Q181619